Pricing
Login
Home
Charts
Search
Watchlist
Products

Cipla Ltd

₹1,415.00-0.25%20 Nov 2026
Reports
Pharma Formulations

Cipla Ltd

₹1,415.00
-0.25%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,14,316Cr
Close
Close Price
₹1,415.00
Industry
Industry
Pharma Formulations
PE
Price To Earnings
39.45
PS
Price To Sales
4.06
Revenue
Revenue
₹28,139Cr
Rev Gr TTM
Revenue Growth TTM
-0.74%
PAT Gr TTM
PAT Growth TTM
-47.41%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
6,6046,1636,6947,0517,0736,7306,9577,5897,0746,5417,1197,404
Growth YoY
Revenue Growth YoY%
13.77.45.85.67.19.23.97.60.0-2.82.3-2.4
Expenses
ExpensesCr
4,8564,8474,9785,1655,0845,1925,1795,6955,8195,5865,9276,016
Operating Profit
Operating ProfitCr
1,7481,3161,7161,8861,9891,5381,7781,8951,2559551,1921,388
OPM
OPM%
26.521.425.626.728.122.925.625.017.714.616.818.7
Other Income
Other IncomeCr
-10249160191222289259269-70148211151
Interest Expense
Interest ExpenseCr
301818151514141314131717
Depreciation
DepreciationCr
233288247272280309253297278383304345
PBT
PBTCr
1,4741,2591,6111,7891,9161,5041,7701,8548937071,0821,177
Tax
TaxCr
405325435483332279478500219157295321
PAT
PATCr
1,0699341,1761,3061,5841,2251,2921,353675550787857
Growth YoY
PAT Growth YoY%
32.278.618.013.048.231.19.83.6-57.4-55.1-39.1-36.7
NPM
NPM%
16.215.217.618.522.418.218.617.89.58.411.111.6
EPS
EPS₹
13.111.614.616.119.415.116.116.78.46.99.810.9
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
6,6046,1636,6947,0517,0736,7306,9577,5897,0746,5417,1197,404
Growth YoY
Revenue Growth YoY%
13.77.45.85.67.19.23.97.60.0-2.82.3-2.4
Expenses
ExpensesCr
4,8564,8474,9785,1655,0845,1925,1795,6955,8195,5865,9276,016
Operating Profit
Operating ProfitCr
1,7481,3161,7161,8861,9891,5381,7781,8951,2559551,1921,388
OPM
OPM%
26.521.425.626.728.122.925.625.017.714.616.818.7
Other Income
Other IncomeCr
-10249160191222289259269-70148211151
Interest Expense
Interest ExpenseCr
301818151514141314131717
Depreciation
DepreciationCr
233288247272280309253297278383304345
PBT
PBTCr
1,4741,2591,6111,7891,9161,5041,7701,8548937071,0821,177
Tax
TaxCr
405325435483332279478500219157295321
PAT
PATCr
1,0699341,1761,3061,5841,2251,2921,353675550787857
Growth YoY
PAT Growth YoY%
32.278.618.013.048.231.19.83.6-57.4-55.1-39.1-36.7
NPM
NPM%
16.215.217.618.522.418.218.617.89.58.411.111.6
EPS
EPS₹
13.111.614.616.119.415.116.116.78.46.99.810.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
13,59514,39415,15616,36217,13219,16021,76322,75325,77427,54828,16328,139
Growth
Revenue Growth%
19.85.95.38.04.711.813.64.513.36.92.2-0.7
Expenses
ExpensesCr
11,11511,91912,32913,26513,92614,90717,21117,72619,48320,42022,28023,349
Operating Profit
Operating ProfitCr
2,4802,4762,8263,0973,2064,2524,5535,0276,2917,1285,8834,790
OPM
OPM%
18.217.218.618.918.722.220.922.124.425.920.917.0
Other Income
Other IncomeCr
20822928047734426699293552862606441
Interest Expense
Interest ExpenseCr
20715911416819716110611090625461
Depreciation
DepreciationCr
7541,3231,3231,3261,1751,0681,0521,1721,0511,1071,2111,310
PBT
PBTCr
1,7271,2221,6692,0792,1783,2903,4934,0385,7026,8215,2243,859
Tax
TaxCr
3321802505706318899341,2031,5471,5301,354991
PAT
PATCr
1,3951,0421,4191,5101,5472,4012,5592,8354,1555,2913,8702,868
Growth
PAT Growth%
11.3-25.336.26.42.555.26.610.846.527.3-26.9-47.4
NPM
NPM%
10.37.29.49.29.012.511.812.516.119.213.710.2
EPS
EPS₹
16.912.517.519.019.229.831.234.751.065.348.035.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
13,59514,39415,15616,36217,13219,16021,76322,75325,77427,54828,16328,139
Growth
Revenue Growth%
19.85.95.38.04.711.813.64.513.36.92.2-0.7
Expenses
ExpensesCr
11,11511,91912,32913,26513,92614,90717,21117,72619,48320,42022,28023,349
Operating Profit
Operating ProfitCr
2,4802,4762,8263,0973,2064,2524,5535,0276,2917,1285,8834,790
OPM
OPM%
18.217.218.618.918.722.220.922.124.425.920.917.0
Other Income
Other IncomeCr
20822928047734426699293552862606441
Interest Expense
Interest ExpenseCr
20715911416819716110611090625461
Depreciation
DepreciationCr
7541,3231,3231,3261,1751,0681,0521,1721,0511,1071,2111,310
PBT
PBTCr
1,7271,2221,6692,0792,1783,2903,4934,0385,7026,8215,2243,859
Tax
TaxCr
3321802505706318899341,2031,5471,5301,354991
PAT
PATCr
1,3951,0421,4191,5101,5472,4012,5592,8354,1555,2913,8702,868
Growth
PAT Growth%
11.3-25.336.26.42.555.26.610.846.527.3-26.9-47.4
NPM
NPM%
10.37.29.49.29.012.511.812.516.119.213.710.2
EPS
EPS₹
16.912.517.519.019.229.831.234.751.065.348.035.9
Sales CAGR
1 Year2%
3 Years7%
5 Years8%
TTM-1%
EBITDA CAGR
1 Year-17%
3 Years5%
5 Years7%
TTM-33%
PAT CAGR
1 Year-27%
3 Years11%
5 Years10%
TTM-47%
Avg. ROCE
1 Year15%
3 Years19%
5 Years18%
TTM11%
CFO / EBITDA
1 Year67%
3 Years68%
5 Years68%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161161161161161161161161161162162162
Reserves
ReservesCr
11,35612,38314,06814,85115,60218,16520,68023,24626,54531,03234,27035,234
Current Liabilities
Current LiabilitiesCr
7,7763,3743,8323,7724,3934,5914,9135,1105,2465,4847,0146,977
Non Current Liabilities
Non Current LiabilitiesCr
1,4864,6814,4474,8483,2121,9751,071640670614962935
Total Liabilities
Total LiabilitiesCr
21,12821,03722,86123,96323,66325,15227,10129,46332,71837,38742,49643,434
Current Assets
Current AssetsCr
8,8418,73610,81412,42711,70613,21014,71116,80519,39223,24924,14625,061
Non Current Assets
Non Current AssetsCr
12,28712,30212,04611,53711,95611,94212,39012,65813,32514,13818,35018,372
Total Assets
Total AssetsCr
21,12821,03722,86123,96323,66325,15227,10129,46332,71837,38742,49643,434
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161161161161161161161161161162162162
Reserves
ReservesCr
11,35612,38314,06814,85115,60218,16520,68023,24626,54531,03234,27035,234
Current Liabilities
Current LiabilitiesCr
7,7763,3743,8323,7724,3934,5914,9135,1105,2465,4847,0146,977
Non Current Liabilities
Non Current LiabilitiesCr
1,4864,6814,4474,8483,2121,9751,071640670614962935
Total Liabilities
Total LiabilitiesCr
21,12821,03722,86123,96323,66325,15227,10129,46332,71837,38742,49643,434
Current Assets
Current AssetsCr
8,8418,73610,81412,42711,70613,21014,71116,80519,39223,24924,14625,061
Non Current Assets
Non Current AssetsCr
12,28712,30212,04611,53711,95611,94212,39012,65813,32514,13818,35018,372
Total Assets
Total AssetsCr
21,12821,03722,86123,96323,66325,15227,10129,46332,71837,38742,49643,434

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,7412,3821,4631,6913,0683,7553,3263,2384,1345,0053,940
Investing Cash Flow
Investing Cash FlowCr
-4,523-1,310-854-1,669104-2,387-1,872-2,389-2,988-3,691-2,326
Financing Cash Flow
Financing Cash FlowCr
3,104-1,326-385-349-2,949-1,240-1,600-958-1,200-1,293-1,234
Net Cash Flow
Net Cash FlowCr
322-254223-326224129-146-109-5521380
Free Cash Flow
Free Cash FlowCr
6881,2848341,3542,5103,1482,7982,4263,0703,8682,364
CFO To PAT
CFO To PAT%
124.8228.5103.1112.0198.3156.4129.9114.299.594.6101.8
CFO To EBITDA
CFO To EBITDA%
70.296.251.854.695.788.373.064.465.770.267.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,7412,3821,4631,6913,0683,7553,3263,2384,1345,0053,940
Investing Cash Flow
Investing Cash FlowCr
-4,523-1,310-854-1,669104-2,387-1,872-2,389-2,988-3,691-2,326
Financing Cash Flow
Financing Cash FlowCr
3,104-1,326-385-349-2,949-1,240-1,600-958-1,200-1,293-1,234
Net Cash Flow
Net Cash FlowCr
322-254223-326224129-146-109-5521380
Free Cash Flow
Free Cash FlowCr
6881,2848341,3542,5103,1482,7982,4263,0703,8682,364
CFO To PAT
CFO To PAT%
124.8228.5103.1112.0198.3156.4129.9114.299.594.6101.8
CFO To EBITDA
CFO To EBITDA%
70.296.251.854.695.788.373.064.465.770.267.0

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
41,14947,65143,73842,64634,10465,74782,17472,6961,20,6731,16,43498,7961,14,316
Price To Earnings
Price To Earnings
30.347.431.027.922.127.332.625.929.322.125.539.5
Price To Sales
Price To Sales
3.03.32.91.81.32.32.82.43.43.12.54.1
Price To Book
Price To Book
3.63.83.12.82.23.63.93.14.53.72.93.2
EV To EBITDA
EV To EBITDA
18.320.716.615.011.215.617.914.319.116.316.723.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
54.855.055.956.957.254.454.056.959.160.658.758.7
OPM
OPM%
18.217.218.618.918.722.220.922.124.425.920.917.0
NPM
NPM%
10.37.29.49.29.012.511.812.516.119.213.710.2
ROCE
ROCE%
11.68.39.711.612.817.016.417.121.221.815.111.0
ROE
ROE%
12.18.310.010.19.813.112.312.115.617.011.28.1
ROA
ROA%
6.65.06.26.36.59.69.49.612.714.29.16.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
41,14947,65143,73842,64634,10465,74782,17472,6961,20,6731,16,43498,7961,14,316
Price To Earnings
Price To Earnings
30.347.431.027.922.127.332.625.929.322.125.539.5
Price To Sales
Price To Sales
3.03.32.91.81.32.32.82.43.43.12.54.1
Price To Book
Price To Book
3.63.83.12.82.23.63.93.14.53.72.93.2
EV To EBITDA
EV To EBITDA
18.320.716.615.011.215.617.914.319.116.316.723.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
54.855.055.956.957.254.454.056.959.160.658.758.7
OPM
OPM%
18.217.218.618.918.722.220.922.124.425.920.917.0
NPM
NPM%
10.37.29.49.29.012.511.812.516.119.213.710.2
ROCE
ROCE%
11.68.39.711.612.817.016.417.121.221.815.111.0
ROE
ROE%
12.18.310.010.19.813.112.312.115.617.011.28.1
ROA
ROA%
6.65.06.26.36.59.69.49.612.714.29.16.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,78,3741,19,7001,16,1191,14,3161,10,0771,03,51092,099
Close PriceClose₹4,689.501,200.001,390.201,415.002,665.001,799.002,014.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE79.2128.6741.3639.4549.0526.0917.24
Price To SalesPS10.253.943.514.067.162.803.00
RevenueRevenueCr17,40030,37833,09728,13915,37936,91330,746
Revenue Growth TTMRev Gr TTM%42.1%24.0%-3.5%-0.7%13.5%13.5%24.2%
PAT Growth TTMPAT Gr TTM%-1.9%-14.6%-51.9%-47.4%27.6%16.5%20.1%
Market CapitalizationMkt CapCr1,78,3741,19,7001,16,1191,14,3161,10,0771,03,51092,099
Close PriceClose₹4,689.501,200.001,390.201,415.002,665.001,799.002,014.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE79.2128.6741.3639.4549.0526.0917.24
Price To SalesPS10.253.943.514.067.162.803.00
RevenueRevenueCr17,40030,37833,09728,13915,37936,91330,746
Revenue Growth TTMRev Gr TTM%42.1%24.0%-3.5%-0.7%13.5%13.5%24.2%
PAT Growth TTMPAT Gr TTM%-1.9%-14.6%-51.9%-47.4%27.6%16.5%20.1%
Interviews